Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR99AHG (mir-99a-let-7c cluster host gene) is a long noncoding RNA that acts as the host gene for the microRNA cluster miR-99a/let-7c/miR-125b2[1][4][5]. It is implicated in several regulatory processes, especially in cancer biology, where it can function as either a tumor suppressor (e.g., in lung adenocarcinoma by promoting autophagy and suppressing proliferation and metastasis) or a pro-metastatic factor (e.g., in colorectal cancer via alternative splicing). MIR99AHG exerts its effects through both its lncRNA transcript (interacting with proteins like ANXA2 and PTBP1 to modulate autophagy and splicing) and its encoded miRNAs that regulate key targets such as mTOR[2][3][5]. In immune response, its altered expression affects macrophage polarization and inflammation in the context of tuberculosis[1]. MIR99AHG and its associated miRNAs are frequently downregulated in cancers (often due to chromosomal deletions), and their expression correlates with patient prognosis, suggesting utility as biomarkers. While currently there are no direct drugs or safety concerns identified, MIR99AHG represents a potential therapeutic and diagnostic target, particularly for tumors with known dysregulation of this pathway[4][5].
Potentially, modulation of gene expression via microRNA cluster activity Regulation of downstream targets (e.g., mTOR signaling, alternative splicing of SMARCA1 via PTBP1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mir-99a-let-7c cluster host gene (MIR99AHG).